G Guagliumi, V Sirbu, H Bezerra… - JACC: Cardiovascular …, 2010 - Elsevier
OBJECTIVES: Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically …
G Guagliumi, V Sirbu, H Bezerra… - JACC …, 2010 - europepmc.org
Objectives Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
G Guagliumi, V Sirbu, H Bezerra… - JACC …, 2010 - academia.edu
Objectives Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
G Guagliumi, V Sirbu, H Bezerra, G Biondi-Zoccai… - 2010 - pubmed.ncbi.nlm.nih.gov
Objectives Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
G Guagliumi, V Sirbu, H Bezerra… - JACC: Cardiovascular …, 2010 - infona.pl
Using optical coherence tomography, we assessed the proportion of uncovered struts at 6- month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor (Medtronic …
G Guagliumi, V Sirbu, H Bezerra… - JACC …, 2010 - iris.uniroma1.it
Objectives Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
G Guagliumi, V Sirbu, H Bezerra… - JACC …, 2010 - core.ac.uk
Objectives Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
G Guagliumi, V Sirbu, H Bezerra… - JACC: Cardiovascular …, 2010 - cir.nii.ac.jp
Strut Coverage and Vessel Wall Response to Zotarolimus-Eluting and Bare-Metal Stents Implanted in Patients With ST-Segment Elevation Myocardial Infarction | CiNii Research CiNii …
G Guagliumi, V Sirbu, H Bezerra… - JACC …, 2010 - academia.edu
Objectives Using optical coherence tomography, we assessed the proportion of uncovered struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …